MedWatch

Leo Pharma owner moves out with the fortune, but maintains control

The Leo Foundation has begun to find its way after increasing the distance to Leo Pharma, however, while the strategy is not fully in place for the foundation's next phase, the main strategy will still be the development of the Danish dermatology company.

Jesper Mailind, CEO at Leo Foundation. | Foto: Leo Fondet

Today, everything changes the Leo Foundation and at the same time nothing changes.

Even though the company has changed its structure and will become a more active player in Denmark and the scientific environment, the main focus of the company will still be the ownership of dermatology company Leo Pharma, says CEO of the Leo Foundation, Jesper Mailind, from his new office in Copenhagen.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Nye insulintilskud bekymrer Diabetesforeningen

Diabetesforeningen er utilfredse med Medicintilskudsnævnets indstilling til en revurdering af tilskud for diabetesmidler, som patientforeningen anser som en spareøvelse uden hensyntagen til patienterne.

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier